Immunolocalization of FGF-1 and receptors in glomerular lesions associated with chronic human renal allograft rejection

Transplantation

Volumn 62, Issue 2, 1996, Pages 190-200

  Kerby, Jeffrey D ^a   Verran, Deborah J ^a   Luo, Kang L ^a   Ding, Qiang ^a   Tagouri, Yahia ^b   Herrera, Guillermo A ^b   Diethelm, Arnold G ^a   Thompson, John A ^a,c  

^a Kentucky   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLOMERULOPATHY; GRAFT REJECTION; GROWTH REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; KIDNEY GRAFT; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY;

ADOLESCENT; ADULT; AGED; FEMALE; FIBROBLAST GROWTH FACTOR 1; GLOMERULONEPHRITIS; GRAFT REJECTION; HUMANS; IN SITU HYBRIDIZATION; KIDNEY; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEPHRECTOMY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, FIBROBLAST GROWTH FACTOR; REFERENCE VALUES; RETROSPECTIVE STUDIES; RNA, MESSENGER;

EID: 0030013411     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199607270-00008     Document Type: Article

References (94)

1. Paul LC, Fellsstrom B. Chronic vascular rejection of the heart and the kidney - have rational treatment options emerged? Transplantation 1992; 53: 1169.
2. Cecka JM, Terasaki PI. The UNOS Scientific Renal Transplant Registry. Clinical Transplant 1993; 1.
3. Almond PS, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
4. Cecka JM. Early rejection: determining the fate of renal transplants. Transplant Proc 1991; 23: 1263.
5. Porter KA. Renal transplantation: pathology of the kidney. 1992; 1799.
6. Hamburger J, Crosnier J, Dormont J. Observations in patients with a well-tolerated homotransplanted kidney: possibility of a new secondary disease. Ann NY Acad Sci 1964; 120: 558.
7. Hamburger J, Crosnier J, Dormont J. Experience with 45 renal homotransplantations in man. Lancet 1965; 1: 985.
8. Peterson EW, McPhaul JJ, McIntosh DA. Serial histologic alterations in human renal homotransplants. Am J Clin Pathol 1966; 45: 521.
9. Porter KA, Dossetor JB, Marchioro TL, et al. Serial histologic alterations in human renal homotransplants. Lab Invest 1967; 16: 153.
10. Starzl TE, Porter KA, Andres G, et al. Long-term survival after renal transplantation in humans. Ann Surg 1970; 172: 437.
11. Busch GJ, Galvanek EG, Reynolds JR. Human renal allografts: analysis of lesions in long-term survivors. Hum Pathol 1971; 2: 253.
12. Zollinger HU, Moppert J, Thiel G, Rohr H. Morphology and pathogenesis of glomerulopathy in cadaver kidney allografts treated with antilymphocyte globulin. Curr Top Pathol 1973; 57: 1.
13. Mathew TH, Mathews DC, Hobbs JB, Kincaid-Smith P. Glomerular lesions after renal transplantation. Am J Med 1975; 59: 177.
14. Manaligod JR, Wellington J, Mozes MF, Jonasson O. Glomerular changes in renal allografts. Am J Kidney Dis 1986; 7: 29.
15. Maryniak IRK, First MR, Weiss MA. Transplant glomerulopathy: evolution of morphologically distinct changes. Kidney Int 1985; 27: 799.
16. Abboud HE, Poptic E, DiCorleto P. Production of platelet-derived growth factor-like protein by rat mesangial cells in culture. J Clin Invest 1987; 80: 675.
17. Shultz PJ, Dicorleto PE, Silver BJ, Abboud HE. Mesangial cells express PDGF mRNAs and proliferate in response to PDGF. Am J Physiol 1988; 255: F674.
18. Jaffer F, Saunders C, Shultz P, Throckmorton D, Weinshell E, Abboud HE. Regulation of mesangial cell growth by polypeptide mitogens. Am J Pathol 1989; 135: 261.
19. Arnqvist HJ, Ballermann BJ, King GL. Receptors for and effects of insulin and IGF-1 in rat glomerular mesangial cells. Am J Physiol 1988; 254: C411.
20. Conti FG, Striker LJ, Lesniak MA, MacKay K, Roth J, Striker GE. Studies on binding and mitogenic effect of insulin and insulin-like growth factor 1 in glomerular mesangial cells. Endocrinology 1988; 122: 2788.
21. Tekeuchi A, Yoshizawa N, Yamamoto M, et al. Basic fibroblast growth factor promotes proliferation of rat glomerular visceral epithelial cells in vitro. Am J Pathol 1992; 141: 107.
22. Nakamura T, Miller D, Ruoslahti E, Border WA. Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1. Kidney Int 1992; 41: 1213.
23. Choi ME, Kim E, Huang Q, Ballerman BJ. Rat mesangial cell hypertrophy in response to transforming growth factor-beta 1. Kidney Int 1993; 44: 948.
24. Silver BJ, Jaffer FE, Abboud HE. Platelet-derived growth factor synthesis in mesangial cells: induction by multiple peptide mitogens. Proc Natl Acad Sci USA 1989; 86: 1056.
25. Doi T, Striker LJ, Quaife C, et al. Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1. Am J Pathol 1988; 131: 398.
26. Quaife CJ, Mathews LS, Pinkert CA, Hammer RE, Brinster RL, Palmiter RD. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinology 1989; 124: 40.
27. Border WA, Okuda S, Languinio LR, Sporn MB, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-beta 1. Nature 1990; 346: 371.
28. Okuda S, Languino LR, Ruoslahti E, Border WA. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. J Clin Invest 1990; 86: 453.
29. Isaka E, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-B or platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993; 92: 2597.
30. Zhao XM, Frist WH, Yeoh TK, Miller GG. Modification of alternative messenger RNA splicing of fibroblast growth factor receptors in human cardiac allografts during rejection. J Clin Invest 1994; 94: 992.
31. Mazue G, Bertolero F, Garofano L, Brughera M, Carminati P. Experience with the preclinical assessment of basic fibroblast growth factor (bFGF). Toxicology Lett 1992; 64/65: 329.
32. Mazue G, Newman AJ, Scampini G, et al. The histopathology of kidney changes in rats and monkeys following intravenous administration of massive doses of FCE 184, human basic fibroblast growth factor. Toxicol Pathol 1993; 21: 490.
33. Floege J, Eng E, Lindner V, et al. Rat glomerular mesangial cells synthesize basic fibroblast growth factor. J Clin Invest 1992; 90: 2362.
34. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235: 442.
35. Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989; 58: 575.
36. Zhan X, Hu X, Friesel R, Maciag T. Long term growth factor exposure and differential tyrosine phosphorylation are required for DNA synthesis in BALBc 3T3 cells. J Biol Chem 1993; 268: 9611.
37. Bouche G, Gas N, Prats H, et al. Basic fibroblast growth factor enters the nucleolus and stimulates the transcription of ribosomal genes in ABAE cells undergoing GO-G1 transition. Proc Natl Acad Sci USA 1987; 84: 6770.
38. Friesel R, Burgess WH, Maciag T. Heparin-binding growth factor 1 stimulates tyrosine phosphorylation in NIH 3T3 cells. Mol Cell Biol 1989; 9: 1857.
39. Johnson DE, Williams LT. Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 1993; 60: 1.
40. Imamura T, Engleka K, Zhan X, et al. Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence. Science 1990; 249: 1567.
41. Zhan X, Hu X, Friedman S, Maciag T. Analysis of endogenous and exogenous nuclear translocation of fibroblast growth factor-1 in NIH 3T3 cells. Biochem Biophys Res Commun 1992; 188: 982.
42. Prudovsky I, Savion N, Zhan X, et al. Intact and functional fibroblast growth factor (FGF) receptor-1 trafficks near the nucleus in response to FGF-1. J Biol Chem 1994; 269: 31720.
43. Gospodarowicz D. Purification of a fibroblast growth factor from bovine pituitary. J Biol Chem 1975; 250: 2515.
44. Gospodarowicz D, Bialecki H, Greenburg G. Purification of the fibroblast growth factor activity from bovine brain. J Biol Chem 1978; 253: 3736.
45. Gautschi-Sova P, Jiang ZP, Frater-Schroder M, Bohlen P. Acidic fibroblast growth factor is present in nonneural tissue: isolation and chemical characterization from bovine kidney. Biochemistry 1987; 26: 5844.
46. Baird A, Esch F, Bohlen P, Ling N, Gospodarowicz D. Isolation and partial characterization of an endothelial cell growth factor from the bovine kidney: homology with basic fibroblast growth factor. Regul Peptide 1985; 12: 201.
47. Risau W, Ekblom P. Production of a heparin-binding angiogenesis factor by the embryonic kidney. J Cell Biol 1986; 103: 1101.
48. Wang W, Lehtoma K, Varban ML, Krishnan I, Chiu IM. Cloning of the gene coding for human class 1 heparin-binding growth factor and its expression in fetal tissues. Mol Cell Biol 1989; 9: 2387.
49. Sullivan DE, Storch TG. Tissue- and development-specific expression of HBGF-1 mRNA. Biochem Biophys Acta 1991; 1090: 17.
50. Vigny M, Ollier-Hartmann MP, Lavigne M, et al. Specific binding of basic fibroblast growth factor to basement membrane-like structures and to purified heparan sulfate proteoglycan of the EHS tumor. J Cell Physiol 1988; 137: 321.
51. Wanaka A, Milbrandt J, Johnson EM, Jr. Expression of FGF receptor gene in rat development. Development 1991; 111: 455.
52. Peters KG, Werner S, Chen G, Williams LT. Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 1992; 114: 233.
53. Peters K, Ornitz D, Werner S, Williams L. Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev Biol 1993; 155: 423.
54. Stark KL, McMahon JA, McMahon AP. FGFR-4, a new member of the fibroblast growth factor receptor family, expressed in the definitive endoderm and skeletal muscle lineages of the mouse. Development 1991; 113: 641.
55. Horlick RA, Stack SL, Cooke GM. Cloning, expression and tissue distribution of the gene encoding rat fibroblast growth factor receptor subtype 4. Gene 1992; 120: 291.
56. Perantoni AO, Dove Lee F, Karavanova I. Basic fibroblast growth factor can mediate the early inductive events in renal development. Proc Natl Acad Sci USA 1995; 92: 4696.
57. Zhang G, Ichimura T, Maier JAM, Maciag T, Stevens JL. A role for fibroblast growth factor type-1 in nephrogenic repair. J Biol Chem 1993; 268: 11542.
58. Hughes SE, Hall PA. Immunolocalization of fibroblast growth factor receptor 1 and its ligands in human tissues. Lab Invest 1993; 69: 173.
59. Kerby JD, Verran D, Luo KL, et al. Immunolocalization of FGF and FGF receptors in the vascular lesions of chronic renal allograft vasculopathy. Transplantation 1996 (in press).
60. Sano H, Forough R, Maier JA, et al. Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints. J Cell Biol 1990; 110: 1417.
61. Forough R, Engleka K, Thompson JA, Jackson A, Imamura T, Maciag T. Differential expression in Escherichia coli of the alpha and beta forms of heparin-binding acidic fibroblast growth factor-1: potential role of RNA secondary structure. Biochim Biophys Acta 1991; 1090: 293.
62. Shi S, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39: 741.
63. Cattoretti G, Becker MHG, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (M1B1 and B1B3) detect proliferating cells in microwave-processed formalin-fixed parafin sections. J Pathol 1992; 168: 357.
64. Mepham BL, Frater W, Mitchell BS. The use of proteolytic enzymes to improve immunoglobulin staining by the PAP technique. Histochem J 1979; 11: 345.
65. Solez K. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
66. LeGuellec P, Dumas S, Volle GE, Pidoux E, Moukhtar MS, Treilhou-Lahille F. An efficient method to detect calcitonin mRNA in normal and neoplastic rat C-cells (medullary thyroid carcinoma) by in situ hybridization using a digoxigenin-labeled synthetic oligodeoxyribonucleotide probe. J Histochem Cytochem 1993; 41: 389.
67. Opalenik SR, Shin JT, Wehby JN, Mahesh VK, Thompson JA. The HIV-1 TAT protein induces the expression and extracellular appearance of acidic fibroblast growth factor. J Biol Chem 1995; 270: 1745.
68. Herrera, GA Lott RL. In: Hayat MA, ed. Colloidal gold: principles, methods and applications, Vol 3. San Diego, CA: Academic, 1991: 321.
69. Rosengart TK, Kuperschmid JP, Maciag T, Clark RE. Pharmacokinetics and distribution of heparin-binding growth factor I (endothelial cell growth factor) in the rat. Circ Res 1989; 64: 227.
70. Nadasdy T, Laszik Z, Blick KE, Johnson LD, Silva FG. Proliferative activity of intrinsic cell populations in the normal human kidney. J Am Soc Nephrol 1994; 4: 2032.
71. Herrera GA, Shultz JJ, Soong SJ, Sanders PW. Growth factors in monoclonal light-chain-related renal diseases. Hum Pathol 1994; 25: 883.
72. Fellstrom B, Klareskog L, Larsson E, et al. Tissue distribution of macrophages, class II transplantation antigens, and receptors for platelet-derived growth factor in normal and rejected human kidneys. Transplant Proc 1987; 19: 3625.
73. Ratner E, Hadley GA, Hanto DW, Mohanakumar T. Immunology of renal allograft rejection. Arch Pathol Lab Med 1991; 115: 283.
74. Brogi E, Winkles JA, Underwood R, Clinton SK, Alberts GF, Libby P. Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. J Clin Invest 1993; 92: 2408.
75. Zhao XM, Yeo TK, Itiebert M, Frist H, Miller GG. Expression of acidic fibroblast growth factor (heparin binding growth factor-1) and cytokine genes in human cardiac allografts and T cells.. Transplantation 1993; 56: 1177.
76. Hostetter TH. Chronic transplant rejection. Kidney Int 1994; 46: 266.
77. Mondermarck H, Courty J, Boilly B, Thomas D. Distribution of intravenously administered acidic and basic fibroblast growth factors in the mouse. Experientia 1990; 46: 973.
78. Polverini PJ, Leibovich SJ. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest 1984; 51: 635.
79. Joseph-Silverstein J, Moscatelli D, Rifkin DB. The identification of bFGF in adherent elicited murine peritoneal macrophages. J Immunol Methods 1988; 110: 183.
80. Monta H, Shinzato T, David G, et al. Basic fibroblast growth factor-binding doman of heparan sulfate in the human glomerulosclerosis and renal tubulointerstitial fibrosis. Lab Invest 1994; 71: 528.
81. Kanwar YS, Liu ZZ, Kashihara N, Wallner E. Current studies of the structural and functional basis of glomerular filtration and proteinuria. Semin Nephrol 1991; 11: 390.
82. Matzner Y, Bar-Ner M, Yahalom J, Ishai-Michaeli R, Fuks Z, Vlodavsky I. Degredation of heparan sulfate in the subendothelial matrix by readily released heparanase from human neutrophils: possible role in invasion through basement membranes. J Clin Invest 1985; 76: 1306.
83. Yahalom J, Eldor A, Fuks Z, Vlodavsky I. Degredation of sulfated proteoglycan in the subendothelial extracellular matrix by human platelet heparitinase. J Clin Invest 1984; 74: 1842.
84. Owens RT, Wagener WD. Condroitin sulfate proteoglycan and heparan sulfate proteoglycan production by cultured pigeon peritoneal macrophages. J Leukoc Biol 1992; 51: 626.
85. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degredation, and cancer. Adv Cancer Res 1985; 44: 139.
86. Ron D, Reich R, Chedid M, et al. Fibroblast growth factor receptor 4 is a high-affinity receptor for both acidic and basic fibroblast growth factor but not for keratinocyte growth factor. J Biol Chem 1993; 268: 5388.
87. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986; 314: 488.
88. Kiefer P, Dickson C. Nucleolar association of fibroblast growth factor 3 via specific sequence motifs has inhibitory effects on cell growth. Mol Cell Biol 1995; 15: 4364.
89. Thompson JA, Anderson KD, DiPietro JM, et al. Site-directed neovessel formation in vivo. Science 1988; 241: 1349.
90. Thompson JA, Haudenschild CC, Anderson KD, DiPietro JM, Anderson WF, Maciag T. Heparin-binding growth factor 1 induces the formation of organoid neovascular structures in vivo. Proc Natl Acad Sci USA 1989; 86: 7928.
91. Walter MA, Jurouglu R, Caulfield J, Vasconez LO, Thompson JA. Enhanced peripheral nerve regeneration by fibroblast growth factor (FGF-1). Lymphokine Cytokine Res 1993; 12: 135.
92. Herrera G, Shultz J, ASCP SH MS, Soong S, Sanders P. Growth factors in monoclonal light-chain-related renal diseases. Hum Pathol 1996; 25: 883.
93. Zeigler ST, Kerby JD, Curiel DT, Diethelm AG, Thompson JA. Molecular conjugate-mediated gene transfer into isolated human kidneys. Transplantation 1996 (in press).
94. Zeigler ST, Kerby J, Curiel D, Wehby J, Diethelm A, Thompson J. Molecular conjugate-mediated gene transfer in renal transplantation. Transplantation Proc 1996 (in press).